Models
Tissue |
Modality |
N |
Adipose |
alternative polyA |
411 |
Adipose |
alternative TSS |
411 |
Adipose |
gene expression |
411 |
Adipose |
isoform ratio |
411 |
Adipose |
intron excision ratio |
411 |
Adipose |
mRNA stability |
411 |
BLA |
alternative polyA |
191 |
BLA |
alternative TSS |
191 |
BLA |
gene expression |
191 |
BLA |
isoform ratio |
191 |
BLA |
intron excision ratio |
191 |
BLA |
mRNA stability |
191 |
Brain |
alternative polyA |
340 |
Brain |
alternative TSS |
340 |
Brain |
gene expression |
340 |
Brain |
isoform ratio |
340 |
Brain |
intron excision ratio |
340 |
Brain |
mRNA stability |
340 |
Eye |
alternative polyA |
53 |
Eye |
alternative TSS |
53 |
Eye |
gene expression |
53 |
Eye |
isoform ratio |
53 |
Eye |
intron excision ratio |
53 |
Eye |
mRNA stability |
53 |
IL |
alternative polyA |
83 |
IL |
alternative TSS |
83 |
IL |
gene expression |
83 |
IL |
isoform ratio |
83 |
IL |
intron excision ratio |
83 |
IL |
mRNA stability |
83 |
LHb |
alternative polyA |
82 |
LHb |
alternative TSS |
82 |
LHb |
gene expression |
82 |
LHb |
isoform ratio |
82 |
LHb |
intron excision ratio |
82 |
LHb |
mRNA stability |
82 |
Liver |
alternative polyA |
411 |
Liver |
alternative TSS |
411 |
Liver |
gene expression |
411 |
Liver |
isoform ratio |
411 |
Liver |
intron excision ratio |
411 |
Liver |
mRNA stability |
411 |
NAcc |
alternative polyA |
270 |
NAcc |
alternative TSS |
270 |
NAcc |
gene expression |
270 |
NAcc |
isoform ratio |
270 |
NAcc |
intron excision ratio |
270 |
NAcc |
mRNA stability |
270 |
OFC |
alternative polyA |
82 |
OFC |
alternative TSS |
82 |
OFC |
gene expression |
82 |
OFC |
isoform ratio |
82 |
OFC |
intron excision ratio |
82 |
OFC |
mRNA stability |
82 |
PL |
alternative polyA |
276 |
PL |
alternative TSS |
276 |
PL |
gene expression |
276 |
PL |
isoform ratio |
276 |
PL |
intron excision ratio |
276 |
PL |
mRNA stability |
276 |